Emeryville Pharmaceutical Services (EPS), an analytical laboratory offering global solutions to its peers in the biotechnology and pharmaceutical industry, have announced the official launch of its service offerings in analytical chemistry and microbiology. EPS is offering state-of-the-art analytical services, including nuclear magnetic resonance spectroscopy (NMR) and liquid chromatography-mass spectrometry (LC-MS), with same day service available for the San Francisco Bay Area. EPS also offers innovative microbiological testing such as comprehensive drug resistance profiling and biofilm modeling.

Dr. Timothy Shiau, Director of Chemistry for Emeryville Pharmaceutical Services, said, 'We are pleased to begin offering our chemical expertise to pharmaceutical and biotechnology companies worldwide. Our team of experts and our cutting-edge equipment will enable scientists to obtain results from complex experiments they may not otherwise have the ability to conduct. The EPS team is looking forward to serving our colleagues in the Bay Area as well as the international research community.'

Dr. Dmitri Debabov, Director for Biology for Emeryville Pharmaceutical Services, added, 'Our expertise in biofilms and biofilm modeling sets us apart from other laboratories and allows us to offer other researchers innovative tools to develop their technologies. With our ability to provide full antibiotic resistance profiling, we expect to be an important resource for companies interested in, or already conducting, antibiotic research.'

Chemistry services include: